News Sentiment

TMCI sentiment intelligence

Treace Medical Concepts Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 69 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 4.32 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

75/100 classification confidence.

Company focus 69

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+2.6% over one week, +6.4% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

Truist Securities Adjusts Price Target on Treace Medical Concepts to $4 From $2, Maintains Hold Rating

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 75/100 classification
One-week reaction 2.6% Price confirming higher
Trend fit Trend active 6.4% over four weeks
Fair value -42.4% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 55
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 69
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 18
TradingKey 5
Quartr 5
Stock Titan 5
TradingView 4
marketscreener.com 3
The National Law Review 3
Finviz 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 27
Analyst action 5
Regulatory and legal 5
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 69
MarketBeat Direct company coverage

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 46.6% in June

Treace Medical Concepts, Inc. (NASDAQ:TMCI) experienced a significant 46.6% decline in short interest in June, bringing the total to 1.75 million shares or about 3.5% of its outstanding shares. Despite weak fundamentals, including a negative net margin and anticipated full-year l

Tone
Neutral 50/100
Event
Earnings
Published
15 Jul 2026 13:45
Source
MarketBeat
Supply Chain Digital Direct company coverage

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)

Johnson Fistel, PLLP is investigating potential breaches of fiduciary duty by officers and directors of Treace Medical Concepts, Inc. (TMCI) on behalf of long-term shareholders who held shares continuously since before May 8, 2023. The investigation focuses on alleged false and m

Tone
Negative 9/100
Event
Regulatory and legal
Published
14 Jul 2026 08:12
Source
Supply Chain Digital
Pluang Direct company coverage

Law firm investigates Treace Medical for alleged false statements affecting shareholders.

Johnson Fistel, PLLP is investigating Treace Medical Concepts, Inc. on behalf of long-term shareholders for alleged breaches of fiduciary duty by its officers and directors. The investigation stems from allegations that Treace made false or misleading statements regarding its bus

Tone
Negative 18/100
Event
Regulatory and legal
Published
13 Jul 2026 14:10
Source
Pluang
The National Law Review Direct company coverage

TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors – Lead Plaintiff Deadline June 10, 2025

Levi & Korsinsky LLP has announced a class action securities lawsuit against Treace Medical Concepts, Inc. (NASDAQ: TMCI) for alleged securities fraud between May 8, 2023, and May 7, 2024. The lawsuit claims that the company made false statements and/or concealed that competition

Tone
Neutral 50/100
Event
Regulatory and legal
Published
01 Jul 2026 08:09
Source
The National Law Review
Finviz Direct company coverage

TMCI - Treace Medical Concepts Inc Volatility & Greeks

This article provides a detailed financial overview of Treace Medical Concepts Inc (TMCI), including its stock performance, key financial metrics, volatility data, and institutional/insider ownership. It covers various ratios, growth rates, and analyst recommendations, offering a

Tone
Neutral 50/100
Event
Analyst action
Published
01 Jul 2026 07:09
Source
Finviz
Finviz Direct company coverage

TMCI - Treace Medical Concepts Inc Earnings

This article provides a detailed financial overview of Treace Medical Concepts Inc (TMCI), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance metrics, insider and institutional ownership, and short i

Tone
Neutral 50/100
Event
Earnings
Published
01 Jul 2026 07:09
Source
Finviz
marketscreener.com Direct company coverage

Treace Medical Concepts, Inc.(NasdaqGS: TMCI) added to Russell Microcap Index

Treace Medical Concepts, Inc. (NasdaqGS: TMCI) has been added to the Russell Microcap Index. This follows several adjustments to Russell indexes, where TMCI was concurrently dropped from other benchmarks including the Russell Small Cap Comp Growth, Russell 2500 Growth, and Russel

Tone
Positive 66/100
Event
Market update
Published
30 Jun 2026 09:11
Source
marketscreener.com
marketscreener.com Direct company coverage

Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from Russell Small Cap Comp Growth Benchmark

Treace Medical Concepts, Inc. (TMCI) has been removed from the Russell Small Cap Comp Growth Benchmark, as well as several other Russell indices including the Russell 2500 Growth Benchmark, Russell 2000 Index, Russell 2500 Index, and Russell 3000 Index. Concurrently, the company

Tone
Negative 40/100
Event
Market update
Published
29 Jun 2026 21:15
Source
marketscreener.com
The National Law Review Direct company coverage

Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Ge

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Treace Medical Concepts, Inc. (NASDAQ: TMCI). The firm encourages investors who purchased Treace Medical securities before May 8, 2023, and still hold them, to contact them to

Tone
Negative 30/100
Event
Regulatory and legal
Published
28 Jun 2026 18:40
Source
The National Law Review
The National Law Review Direct company coverage

Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Investors - Lead Plaintiff Deadline on June 10, 2025

Levi & Korsinsky has announced a lead plaintiff deadline of June 10, 2025, for investors of Treace Medical Concepts, Inc. (TMCI) who suffered losses due to alleged securities fraud. The class action lawsuit claims the company made false statements about competition impacting dema

Tone
Negative 30/100
Event
Regulatory and legal
Published
27 Jun 2026 13:40
Source
The National Law Review
TradingView Direct company coverage

Price to earnings forward of Treace Medical Concepts, Inc. – NASDAQ:TMCI

This article briefly presents the "Price to earnings forward" value for Treace Medical Concepts, Inc. (NASDAQ: TMCI). The content, likely from a financial data platform, shows the value for a specific period without providing further details or analysis.

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 19:11
Source
TradingView
富途牛牛 Direct company coverage

Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its First-Quarter Results

This article states that analysts are updating their estimates for Treace Medical Concepts, Inc. (NASDAQ:TMCI) following the release of its first-quarter results. The content is missing, preventing a detailed summary of the company's performance or analyst reactions.

Tone
Positive 59/100
Event
Earnings
Published
25 Jun 2026 17:39
Source
富途牛牛
TradingView Direct company coverage

Enterprise value to revenue forward of Treace Medical Concepts, Inc. – NASDAQ:TMCI

The article provides the enterprise value to revenue forward for Treace Medical Concepts, Inc. (NASDAQ: TMCI). It lists the current value, change, and percentage change for this financial metric. The content appears to be a snapshot from a financial data platform, likely TradingV

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 10:09
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Treace Medical Concepts, Inc. – BOATS:TMCI

This page from TradingView displays the "price to earnings forward" metric for Treace Medical Concepts, Inc. (TMCI) under its Blue Ocean Alternative Trade System (BOATS) listing. It appears to be a financial data point for the company, accessible within a broader financial and ma

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 09:09
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Treace Medical Concepts, Inc. – NASDAQ:TMCI

This article provides financial information for Treace Medical Concepts, Inc. (NASDAQ: TMCI), specifically focusing on its enterprise value to forward EBITDA. The content appears to be a stub or an incomplete data presentation page from TradingView, indicating financial metrics w

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 19:40
Source
TradingView
TradingKey Direct company coverage

Treace Medical Concepts Inc (TMCI) Institutional Confidence

The article analyzes the institutional confidence in Treace Medical Concepts Inc (TMCI), noting its current institutional shareholding score of 5.00, placing it 109th out of 204 in the Healthcare Equipment & Supplies industry. It highlights that the latest institutional sharehold

Tone
Positive 72/100
Event
Market update
Published
22 Jun 2026 15:39
Source
TradingKey
Quartr Direct company coverage

Treace Medical Concepts (TMCI) Sidoti Small-Cap Virtual Investor Conference Summary

This article summarizes Treace Medical Concepts' (TMCI) presentation at the Sidoti Small-Cap Virtual Investor Conference. Key takeaways include the company's strategic focus on 3D bunion correction, expansion into new product lines, and positive financial performance with improve

Tone
Positive 72/100
Event
Market update
Published
20 Jun 2026 04:39
Source
Quartr
Quartr Direct company coverage

Treace Medical Concepts (TMCI) Q3 2024 earnings summary

Treace Medical Concepts (TMCI) reported Q3 2024 revenue of $45.1 million, an 11% increase year-over-year, and a net loss of $15.4 million ($0.25 per share), an improvement from the prior year. The company launched the Nanoplasty 3D MIS system and is pursuing patent litigation. TM

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 19:41
Source
Quartr
Quartr Direct company coverage

Treace Medical Concepts (TMCI) Proxy filing Summary

Treace Medical Concepts (TMCI) released a summary of its proxy filing for the upcoming annual meeting on May 19, 2026. Key highlights from 2025 include the launch of new minimally invasive bunion correction systems, expansion into biologics, and $212.7 million in revenue. Shareho

Tone
Positive 61/100
Event
Earnings
Published
19 Jun 2026 18:41
Source
Quartr
Quartr Direct company coverage

Treace Medical Concepts (TMCI) Q2 2024 earnings summary

Treace Medical Concepts (TMCI) reported Q2 2024 revenue of $44.5 million, marking a 6% year-over-year increase, driven by higher case volumes and new product adoption. Despite revenue growth, the company's net loss widened to $21.2 million due to increased operating expenses and

Tone
Neutral 50/100
Event
Earnings
Published
19 Jun 2026 18:39
Source
Quartr
Quartr Direct company coverage

Treace Medical Concepts (TMCI) 2024 Truist Securities MedTech Conference Summary

Treace Medical Concepts (TMCI) presented at the 2024 Truist Securities MedTech Conference, highlighting market evolution, growth opportunities, and strategic responses to increased competition. The company plans to launch two minimally invasive osteotomy platforms by late 2024 to

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 01:39
Source
Quartr
markets.businessinsider.com Direct company coverage

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

Treace Medical Concepts, Inc. announced the successful completion of the first surgical case using its new HyperPlate™ XM Dynamic Compression Locking Implant system. This system, designed for midfoot and hindfoot fusion procedures, offers enhanced stability and dynamic compressio

Tone
Positive 72/100
Event
Market update
Published
18 Jun 2026 11:09
Source
markets.businessinsider.com
Stock Titan Direct company coverage

Treace treats its first patient with HyperPlate XM foot implant

Treace (Nasdaq: TMCI) has successfully completed the first surgical case using its new HyperPlate™ XM Dynamic Compression Locking Implant, an extension of its SpeedPlate platform for midfoot and hindfoot fusion procedures and osteotomies. The titanium system features FastPitch lo

Tone
Positive 72/100
Event
Market update
Published
18 Jun 2026 11:09
Source
Stock Titan
TradingKey Direct company coverage

Treace Medical Concepts Inc (TMCI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution — TradingKey

The article provides a snapshot of Treace Medical Concepts Inc. (TMCI) stock performance, showing a slight increase of 1.39%. It highlights the company's market capitalization but notes that relevant data regarding revenue breakdown by business segments and regions has not yet be

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 09:09
Source
TradingKey
TradingKey Direct company coverage

Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Treace Medical Concepts Inc (TMCI), noting its current earnings forecast score is 6.00 and ranks 169 out of 203 in the Healthcare Equipment & Supplies industry. Analysts have a "Hold" rating on the stock with an average price target o

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 02:39
Source
TradingKey
TradingKey Direct company coverage

Treace Medical Concepts Inc (TMCI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Treace Medical Concepts Inc (TMCI), listing major individual and institutional investors. It provides a breakdown of shareholder types, institutional holdings over several recent quarters, and recent shareholder activities includi

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:09
Source
TradingKey